Citadel Advisors
CUE icon

Citadel Advisors’s Cue Biopharma CUE Stock Holding History

Citadel Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92K Buy
+423
New +$3.95K ﹤0.01% 12829
2025
Q2 		– Sell
-47
Closed -$1.27K – 12913
2025
Q1 		$1.27K Buy
47
+7
+18% +$260 ﹤0.01% 14150
2024
Q4 		$1.31K Sell
40
-47
-54% -$1.77K ﹤0.01% 14204
2024
Q3 		$1.97K Sell
87
-283
-76% -$6.13K ﹤0.01% 13792
2024
Q2 		$13.8K Buy
370
+160
+76% +$7.91K ﹤0.01% 12923
2024
Q1 		$11.9K Buy
210
+163
+347% +$11.5K ﹤0.01% 13383
2023
Q4 		$3.7K Sell
47
-200
-81% -$14.3K ﹤0.01% 13568
2023
Q3 		$17K Buy
247
+30
+14% +$2.93K ﹤0.01% 12747
2023
Q2 		$23.7K Buy
217
+134
+161% +$15.7K ﹤0.01% 12585
2023
Q1 		$8.93K Buy
83
+3
+4% +$286 ﹤0.01% 13620
2022
Q4 		$6.84K Buy
+80
New +$7.32K ﹤0.01% 13879
2022
Q3 		– Sell
-513
Closed -$38K – 12759
2022
Q2 		$38K Sell
513
-70
-12% -$8.19K ﹤0.01% 12090
2022
Q1 		$85K Buy
583
+16
+3% +$3.39K ﹤0.01% 12426
2021
Q4 		$192K Buy
567
+210
+59% +$81.2K ﹤0.01% 11900
2021
Q3 		$156K Sell
357
-1,990
-85% -$694K ﹤0.01% 12331
2021
Q2 		$820K Sell
2,347
-2,233
-49% -$866K ﹤0.01% 8879
2021
Q1 		$1.68M Buy
4,580
+107
+2% +$44K ﹤0.01% 6833
2020
Q4 		$1.68M Buy
+4,473
New +$1.79M ﹤0.01% 5737

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Citadel Advisors's CUE Position: Q3 2024 in Review

Citadel Advisors sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 2,776 shares — an estimated $60.1K sold.

Citadel Advisors first reported a position in CUE in Q1 2020 and held it in 15 quarters. The position peaked at $6.69M in Q2 2020. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Citadel Advisors reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,776 Cue Biopharma shares in Q3 2024, an estimated $60.1K.
  • Citadel Advisors first reported a position in Cue Biopharma in Q1 2020 and held it in 15 quarters.
  • Citadel Advisors's Cue Biopharma position peaked at $6.69M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.